Cypress Diagnostics is a healthcare startup based in Belgium that aims to revolutionize the way patients and doctors approach routine testing. Established in 1995, the company envisions supplying 100 million screening and monitoring tests per year by 2030.
By providing quick and clear solutions for the most common conditions, Cypress Diagnostics empowers healthcare professionals to make informed decisions regarding treatments. The company prioritizes proximity to the patient, aiming to bring primary and secondary healthcare units to communities, thereby saving time, suffering, and ultimately, lives.
Despite not having a record of recent investments or known investors, the company's commitment to improving patient care and its ambitious goal of making the world a better place through each test demonstrate its potential for growth and impact in the healthcare industry.